Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Omeros CorporationNASDAQ: OMER
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA turns positive
Q1 FY2026 EBITDA was $57.44M, compared with -$33.62M a year earlier. Trailing-twelve-month EBITDA was $92.9M.
Context
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 2 analysts of $0 (+100.0%) for the fiscal year ending Dec 2026, a step up from the +98.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $57.44M-30.1% QoQ
- Last fiscal yearDec 2025
- -$1.83M+98.8% YoY
- LTMMar 2026
- $92.9M+159.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +270.8% | +100.0% | -170.8 pp |
| 1 year | +98.8% | +100.0% | +1.2 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (1.83M) USD
- Year-over-year change
- +98.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.83M) | +98.8% |
| FY2024 | 2024-12-31 | (157M) | -9.7% |
| FY2023 | 2023-12-31 | (143.16M) | +9.6% |
| FY2022 | 2022-12-31 | (158.38M) | +7.1% |
| FY2021 | 2021-12-31 | (170.49M) | — |
EBITDA vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 EBITDA of $92.9M is the highest of the 11 companies compared; the peer median is -$87.12M.
- Its year-over-year change of +159.9% is the 3rd highest of 11, against a peer median of -4.7%.
- EBITDA amounts to 939.0% of revenue for OMER, versus a peer median of 117.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $92.9M | +159.9% | — | 939.0% | |
| LTM Mar 2026 | $58.49M | +176.6% | — | 25.2% | |
| LTM Mar 2026 | $34.88M | +463.6% | — | 48.0% | |
| LTM Mar 2026 | -$39.29M | +13.4% | — | 7858.4% | |
| LTM Mar 2026 | -$42.27M | -2.3% | — | — | |
| LTM Mar 2026 | -$50.64M | -7.0% | — | 32.2% | |
| LTM Jun 2026 | -$123.6M | -14.3% | — | 117.7% | |
| LTM Jun 2026 | -$134.39M | -53.9% | — | 246.2% | |
| LTM Mar 2026 | -$220.73M | -23.8% | — | — | |
| LTM Jun 2026 | -$419M | -48.6% | — | 358.1% | |
| LTM Jun 2026 | -$574.94M | +24.1% | — | — | |
| Peer median (excluding OMER) | -$87.12M | -4.7% | — | 117.7% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.39M | 0 | 0 | 0 | 0 |
| Gross Profit | (1.39M) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 118.78M | 112.72M | 114.87M | 119.52M | 81.3M |
| Selling, General & Admin | 53.46M | 50.67M | 49.66M | 49.74M | 41.5M |
| Operating Expenses | 172.23M | 163.39M | 164.53M | 169.26M | 122.8M |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| EBITDA | (170.49M) | (158.38M) | (143.16M) | (157M) | (1.83M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (173.62M) | (163.39M) | (164.53M) | (169.26M) | (122.8M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17.93K | 4.06M | 16.34M | 11.3M | 5.06M |
| Interest Expense | 19.67M | 22.7M | 30.84M | 24.68M | 0 |
| Other Income / Expenses | (17.93M) | (18.64M) | (10.39M) | (13.37M) | 120M |
| Income Before Tax | (191.55M) | (182.03M) | (174.92M) | (182.63M) | (2.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 2.01M |
| Net Income | (111.41M) | 47.42M | (117.81M) | (156.82M) | (3.35M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| EPS (Diluted) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| Weighted Avg Shares | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
| Weighted Avg Shares (Diluted) | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.